Literature DB >> 28687686

Isolated insulin-derived amyloidoma of the breast.

Jonathan Mark Mayhew1, Tanya Alan1, Venu Kalidindi1, Tasha A K Gandamihardja1.   

Abstract

Isolated amyloidomas derived from insulin are extremely rare, and there is only one reported case to date of insulin-derived amyloidoma in the breast.We present the case of a 36-year-old woman reporting a lump in the right breast. It was clinically assessed as a probable fibroadenoma but was removed surgically given the size of the lesion. On histological analysis, the lesion had features consistent with amyloid. Further investigations showed the amyloid to be derived from insulin. The lump was removed in its entirety, and the patient made a full recovery. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Breast surgery; Pathology

Mesh:

Substances:

Year:  2017        PMID: 28687686      PMCID: PMC5534719          DOI: 10.1136/bcr-2017-219491

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Proinsulin C-peptide interferes with insulin fibril formation.

Authors:  Michael Landreh; Jan-Bernd Stukenborg; Hanna Willander; Olle Söder; Jan Johansson; Hans Jörnvall
Journal:  Biochem Biophys Res Commun       Date:  2012-01-18       Impact factor: 3.575

2.  Localized amyloidosis of the breast: a case series.

Authors:  Marjory Charlot; David C Seldin; Carl O'hara; Martha Skinner; Vaishali Sanchorawala
Journal:  Amyloid       Date:  2011-04-18       Impact factor: 7.141

Review 3.  Insulin amyloid at injection sites of patients with diabetes.

Authors:  Melanie R Nilsson
Journal:  Amyloid       Date:  2016-05-09       Impact factor: 7.141

Review 4.  Primary amyloid tumour of the breast: a case report.

Authors:  M V Deolekar; J Larsen; J A Morris
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

5.  Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report.

Authors:  Saniye Yumlu; Robert Barany; Magdalena Eriksson; Christoph Röcken
Journal:  Hum Pathol       Date:  2009-08-14       Impact factor: 3.466

6.  Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis.

Authors:  Jean D Sipe; Merrill D Benson; Joel N Buxbaum; Shu-ichi Ikeda; Giampaolo Merlini; Maria J M Saraiva; Per Westermark
Journal:  Amyloid       Date:  2012-11-01       Impact factor: 7.141

7.  Insulin-derived amyloidosis.

Authors:  Yashdeep Gupta; Gaurav Singla; Rajiv Singla
Journal:  Indian J Endocrinol Metab       Date:  2015 Jan-Feb
  7 in total
  5 in total

1.  Impact of Insulin-Derived Amyloidosis on Glycemic Control and Insulin Dosing.

Authors:  Aaron Estep; Jarrod Uhrig; Curtis Bower; Robert Jarrett
Journal:  Clin Diabetes       Date:  2022

2.  Local Insulin-Derived Amyloidosis Model Confronted with Silymarin: Histological Insights and Gene Expression of MMP, TNF-α, and IL-6.

Authors:  Katia Azarfar; Parichehreh Yaghmaei; Mahsa M Amoli; Nasim Hayati-Roodbari; Azadeh Ebrahim-Habibi
Journal:  Int J Mol Sci       Date:  2022-04-29       Impact factor: 6.208

3.  Subcutaneous amyloidoma models for screening potential anti-fibrillating agents in vivo.

Authors:  Debajyoti Das; Avishek Paul; Sujay Krishna Maity; Subhrangsu Chatterjee; Partha Chakrabarti
Journal:  STAR Protoc       Date:  2021-12-14

4.  Determination of amyloid core regions of insulin analogues fibrils.

Authors:  Alexey K Surin; Sergei Yu Grishin; Oxana V Galzitskaya
Journal:  Prion       Date:  2020-01-01       Impact factor: 3.931

5.  Quantitative evaluation of insulin-induced abdominal subcutaneous dystrophic tissue using shear wave elastography.

Authors:  Genki Sato; Hiroshi Uchino; Yosuke Shimizu; Junko Tatebe; Toshisuke Morita; Takahisa Hirose
Journal:  J Diabetes Investig       Date:  2022-02-11       Impact factor: 3.681

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.